← Back to Search

Group Self-Management Support for Anxiety Disorders

N/A

Waitlist Available

Led By Pasquale Roberge, Ph.D.

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Severe depressive symptoms

Cognitive impairment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to study if a virtual group self-management support program can help people with anxiety disorders when added to their usual treatment. The study will evaluate the effectiveness and cost of this program compared to standard

Who is the study for?

This trial is for adults over 18 in Quebec who speak French and have been diagnosed with anxiety disorders like Panic Disorder, Agoraphobia, Generalized Anxiety Disorder, or Social Anxiety Disorder. They must have internet access and a device with a microphone and camera to participate.

What is being tested?

The study tests a virtual group self-management support program as an addition to usual care for managing anxiety. It's compared against the standard treatment without this program. The effectiveness will be measured at different intervals up to two years after starting.

What are the potential side effects?

Since the intervention involves educational and self-help strategies rather than medication, no direct medical side effects are expected. Participants may experience discomfort discussing personal experiences or temporary increases in anxiety when confronting their symptoms.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am experiencing severe depression.

Select...

I have trouble with memory or thinking clearly.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post-treatment, and 8-month, 12-month, 24-month post-randomization follow-ups for reporting.